(KTRA-DD) Market Cap only 34 million/ Cash balance 23 million / 2 Cancer Drugs to start Phase 3 imminent -HUGE commercial opp of over $1+ Billion / LOTS of upcoming Major milestones (see Chart below) including Phase 2 readout of the Newly diagnosed GBM Study = MASSIVE Underpriced stock with significant upside potential could run to 10 dollar and more on positive readouts .GL Kintara Therapeutics (KTRA) Market Cap $33 Million Cash $23 Million Price $1.35 Shares Out 24.6 Million Company Presentation https://d1io3yog0oux5.cloudfront.ne...pdf/Kintara+Therapeutics+Deck+08+31+FINAL.pdf 3 “Strong Buy” Healthcare Stocks Under $5 That Could Go Boom.. https://finance.yahoo.com/news/3-strong-buy-healthcare-stocks-193054154.html
